Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes - Concepedia

Concepedia

Publication | Open Access

Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes

DOI Full Paper Access

28

Citations

22

References

2019

Year

Alessio Cortellini, Alessandro Leonetti, Annamaria Catino, P. Pizzutillo, Biagio Ricciuti, Andrea De Giglio, Rita Chiari, Paola Bordi, Daniele Santini, Raffaele Giusti,

Clinical & Translational Oncology

SclerostinDisease ProgressionClinical TrialsMulticenter StudyMedicine

References

	Year	Citations

Page 1